Search results
AbbVie inks immune disorder drug licensing deal with China's FutureGen
Reuters via Yahoo News· 12 hours agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
CNN via Yahoo News· 3 days agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed ...
Future of Chromatography Resins: Improved Resolution in Bioprocessing, Upcoming Webinar Hosted by...
PRWeb· 13 hours agoChromatography resins are crucial in the purification process of biotherapeutic products, including everything from monoclonal antibodies to cell and gene therapies. With increase in the awareness ...
Acticor Biotech Fab Fragment Development & Manufacturing
BioresearchOnline· 1 day agoGlenzocimab (ACT017) is a humanized Fab fragment of a monoclonal antibody, targeting platelet...
Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024
FOX 16 Little Rock· 7 days agoThe 2024 American Society of Clinical Oncology (ASCO) Annual Meeting convened from May 31 to June 4, 2024 in Chicago, USA, adopting a hybrid format. Among the presented works, three clinical ...
'Something I never saw coming': Canadian powerlifter spent 5 weeks on life support after developing...
Yahoo Canada Style· 1 day agoThis article is for informational purposes only and is not a substitute for professional medical...
Independent FDA Panel Endorses New Alzheimer’s Disease Treatment
WebMD· 3 days agoThe treatment can cause brain swelling or brain bleeding. Ultimately, advisors agreed that donanemab is safe and that the treatment’s benefits outweigh the risks. If fully approved, donanemab ...
Anti-CD20 HGG Linked to Serious Infection Risk in MS
Medscape· 7 days agoHypogammaglobulinemia is a known risk linked to B-cell–depleting therapies, but a real-world study has specified the risk and risk factors in multiple...
Dianthus receives FDA greenlight to begin Phase II trial in MMN
Clinical Trials Arena via Yahoo Finance· 1 day agoInitial top-line results are slated for the second half of 2026, according to the US biotech....
New platform streamlines epitope comparison in antibody research
Medical Xpress· 3 days agoMonoclonal antibodies are crucial therapeutics due to their high specificity and binding affinity...